| Item Type | Name |
|
Concept
|
Patient Admission
|
|
Concept
|
Patient Care Planning
|
|
Concept
|
Patient Discharge
|
|
Concept
|
Patient Education as Topic
|
|
Concept
|
Patient Satisfaction
|
|
Concept
|
Patient-Centered Care
|
|
Concept
|
Patient Selection
|
|
Academic Article
|
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
|
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
|
Academic Article
|
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
|
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
|
Academic Article
|
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
|
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
|
|
Academic Article
|
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
|
|
Academic Article
|
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
|
|
Academic Article
|
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial.
|
|
Academic Article
|
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
|
|
Academic Article
|
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
|
|
Academic Article
|
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
|
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
|
Academic Article
|
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
|
|
Academic Article
|
Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
|
|
Academic Article
|
Pharmacokinetics and dynamics of heparin in patients with proximal vein thrombosis.
|
|
Academic Article
|
A new noninvasive management strategy for patients with suspected pulmonary embolism.
|
|
Academic Article
|
Preventing systemic embolism in patients with abnormal ventricular function.
|
|
Academic Article
|
Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.
|
|
Academic Article
|
Pulmonary embolism among patients with a nearly normal ventilation/perfusion lung scan.
|
|
Academic Article
|
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
|
|
Academic Article
|
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
|
|
Academic Article
|
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
|
|
Academic Article
|
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
|
|
Academic Article
|
Global public awareness of venous thromboembolism.
|
|
Academic Article
|
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
|
|
Academic Article
|
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
|
|
Academic Article
|
New paradigms in venous thromboprophylaxis of medically ill patients.
|
|
Academic Article
|
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
|
|
Academic Article
|
Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis.
|
|
Academic Article
|
Clinical implications of incidental venous thromboembolism in cancer patients.
|
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
|
|
Academic Article
|
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
|
|
Academic Article
|
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
|
|
Academic Article
|
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
|
|
Academic Article
|
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
|
Academic Article
|
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.
|
|
Academic Article
|
Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.
|
|
Academic Article
|
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
|
|
Academic Article
|
Helical computed tomography and magnet resonance imaging: diagnosis of pulmonary embolism in symptomatic patients.
|
|
Academic Article
|
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings.
|
|
Academic Article
|
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
|
|
Academic Article
|
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
|
|
Academic Article
|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
|
|
Academic Article
|
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
|
|
Academic Article
|
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism.
|
|
Academic Article
|
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
|
|
Academic Article
|
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.
|
|
Academic Article
|
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
|
|
Academic Article
|
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
|
|
Academic Article
|
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
|
|
Academic Article
|
Design of the REVEAL registry for US patients with pulmonary arterial hypertension.
|
|
Academic Article
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
|
Academic Article
|
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
|
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
|
|
Academic Article
|
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
|
|
Academic Article
|
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
|
|
Academic Article
|
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
|
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
|
|
Academic Article
|
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
|
|
Academic Article
|
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
|
|
Academic Article
|
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
|
|
Academic Article
|
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism.
|
|
Academic Article
|
Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings.
|
|
Academic Article
|
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.
|
|
Grant
|
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
|
|
Academic Article
|
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
|
|
Academic Article
|
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
|
|
Academic Article
|
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
|
|
Academic Article
|
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
|
|
Academic Article
|
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
|
|
Academic Article
|
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
|
|
Academic Article
|
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
|
|
Academic Article
|
Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study.
|
|
Academic Article
|
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
|
|
Academic Article
|
Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial.
|